Not Signed In - Lupin Receives Final Approval For Lisinopril-HCTZ Tablets
Fri, 29 Sep 2006 07:00 AM EST
... Lupin Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted final approval for its Abbreviated New Drug Application (ANDA) for Lisinopril and Hydrochlorothiazide tablets in 10mg/12.5mg, 20mg/12.5mg and 20mg/25mg strengths. Lupin's Lisinopril-HCTZ tablets are the AB-rated generic equivalent of Prinzide(R) Tablets of Merck & Co., Inc. [click link for full article] ...
Related Topics
- Lisinopril
- Carbinoxamine and Pseudoephedrine Tablets
- Lisinopril and Hydrochlorothiazide
- Triamterene
- Hydrochlorothiazide
- Vaccine Testing & Approval
- Carbinoxamine and Pseudoephedrine Extended-Release Tablets
- Cyanocobalamin Tablets
- Chlorpheniramine, Pseudoephedrine and Hydrocodone Tablets
- Guaifenesin and Dextromethorphan
- Neostigmine Tablets
- Thiabendazole Tablets
- Haloperidol Tablets
- Carbetapentane, Phenylephrine, and Pyrilamine
- Benazepril
- Ergoloid Mesylates Sublingual Tablets
- Nystatin Tablets
- Desmopressin Tablets
- Isosorbide Dinitrate, Tablets or Extended-Release Tablets or Capsules
- Tarceva
email this page
print this page
bookmark this page
feedback on this page
